🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Argentina makes headway in establishing a cannabis export industry

Published 03/08/2023, 06:19 AM
Updated 03/08/2023, 06:22 AM
© Reuters. A marijuana plant is pictured at the state-owned medical cannabis research and development center (CIDCam), as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plan

MONTE VERA, Argentina (Reuters) - Argentina's new cannabis watchdog is overseeing more than 50 projects related to the research and development of cannabis and is establishing a regulatory framework as it bids to enter the potentially lucrative weed export market.

"The industry has incredible potential," said Gabriel Gimenez, director of the ARICCAME cannabis agency created in January this year, last week.

He said 51 regulated research and development projects are currently taking place around the country, including Cannava in Jujuy province, Agrogenetica Riojana in La Rioja, Biofabrica in Misiones and Medicinal Cannabis in San Juan.

Argentina is looking to build its domestic medical cannabis market and generate foreign currency through exports. It allows cannabis-derived products in pharmacies and has ordered insurers to cover prescriptions for marijuana-based medications, but recreational use is still forbidden.

The country's National Seed Institute has currently authorized 13 traceable types of cannabis seed.

In Santa Fe province, the medical cannabis research and development center (CIDCam), which has over 200 cannabis plants of various varieties, is expecting a second harvest this month. The project is intended to help producers experiment with different genetics.

Argentina is hoping the industry could generate 10,000 direct jobs, $500 million in domestic sales and $50 million in exports by 2025, according to a report from the Ministry of Productive Development.

Local firm Pampa Hemp was the first private venture authorized by the health ministry. It started cultivation in 2021 of pharmaceutical-grade cannabis at an experimental station in Buenos Aires province.

Pablo Fazio, president of the Argentine Chamber of Cannabis (ARGENCANN) and Pampa Hemp's co-founder, said demand could ignite a new domestic industry for products made from the raw material. "That in itself is a revolution," he said.

The chamber comprises some 200 private firms either directly or indirectly linked to the industrial hemp and medical cannabis business.

© Reuters. A marijuana plant is pictured at the state-owned medical cannabis research and development center (CIDCam), as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Monte Vera, Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto

Latin American countries have been gradually loosening restrictions around the cultivation, distribution, and consumption of cannabis.

Argentina's smaller neighbor Uruguay was the first modern country to explicitly legalize marijuana in 2013, while recent legislation in Paraguay is seeking to legalize cultivation for medical use.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.